in the United States: Treatment utilization and prognostic factors.
Establishment and characterization of a human adrenocortical carcinoma
cell line that expresses multiple pathways of steroid biosynthesis.
(ACCs) are highly aggressive uncommon malignancies with a worldwide incidence of about 0.
account for 14% of all incidentalomas.
Identify and understand important and diverse types of therapeutics under development for Adrenocortical Carcinoma
(Adrenal Cortex Cancer).
(ACC) is a rare, malignant tumor of the adrenal gland.
Pathologic features of prognostic significance in adrenocortical carcinoma
," American Journal of Surgical Pathology, vol.
Renal cell carcinoma and adrenocortical carcinoma
are usually readily diagnosed clinically and radiographically.
Among patients with adrenal masses Adrenocortical carcinoma
(ACC) and malignant pheochromocytomas (MPH) are found with a low incidence but very unfavorable prognosis.
Although laparoscopic adrenalectomy represents the standard of care in managing adrenal masses, open surgery still has a major role in management of adrenal masses, suspected to be adrenocortical carcinoma
The human adrenocortical carcinoma
cell line H295R expresses all key enzymes involved in the synthesis of adrenocorticol steroid hormones from cholesterol and is being evaluated as a potential screening assay for EACs with effects on steroid biosynthesis.
(Adrenal Cortex Cancer) - Pipeline Review, H1 2012', provides an overview of the Adrenocortical Carcinoma
(Adrenal Cortex Cancer) therapeutic pipeline.